{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:54:13Z","timestamp":1793091253045,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2023-MS-189"],"award-info":[{"award-number":["2023-MS-189"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.intimp.2024.112816","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T15:34:18Z","timestamp":1722353658000},"page":"112816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Evaluation of the adjuvant effect of imiquimod and CpG ODN 1826 in chimeric DNA vaccine against Japanese encephalitis"],"prefix":"10.1016","volume":"140","author":[{"given":"Xin","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112816_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100994","article-title":"Pathobiology of Japanese encephalitis virus infection","volume":"81","author":"Sharma","year":"2021","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.intimp.2024.112816_b0010","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2337677","article-title":"Peripheral nerve injury associated with JEV infection in high endemic regions, 2016\u20132020: a multicenter retrospective study in China","author":"Wang","year":"2024","journal-title":"Emerg. Microbes Infect."},{"issue":"8","key":"10.1016\/j.intimp.2024.112816_b0015","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5694\/mja2.51905","article-title":"Japanese encephalitis virus: changing the clinical landscape of encephalitis in Australia","volume":"218","author":"Allen","year":"2023","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.intimp.2024.112816_b0020","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2343910","article-title":"Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus","author":"Kim","year":"2024","journal-title":"Emerg. Microbes Infect."},{"issue":"8","key":"10.1016\/j.intimp.2024.112816_b0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/14712598.2018.1499721","article-title":"Recent developments in vaccines and biological therapies against Japanese encephalitis virus","volume":"18","author":"Barzon","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"issue":"29","key":"10.1016\/j.intimp.2024.112816_b0030","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.vaccine.2018.04.038","article-title":"Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012\u20132016","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.intimp.2024.112816_b0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14787210.4.2.313","article-title":"Japanese encephalitis: development of new candidate vaccines","volume":"4","author":"Bharati","year":"2006","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.intimp.2024.112816_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103678","article-title":"Japanese encephalitis virus: associated immune response and recent progress in vaccine development","volume":"136","author":"Kumar","year":"2019","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.intimp.2024.112816_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020423","article-title":"Recent advances in the development of toll-like receptor agonist-based vaccine adjuvants for infectious diseases","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.intimp.2024.112816_b0050","article-title":"Functions and cellular signaling by ribosomal extracellular RNA (rexRNA): facts and hypotheses on a non-typical DAMP","volume":"1870","author":"Preissner","year":"2023","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.intimp.2024.112816_b0055","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/CVI.00816-13","article-title":"Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB\/c mice","volume":"21","author":"Zhang","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.intimp.2024.112816_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112816_b0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41698-023-00364-1","article-title":"Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer","volume":"7","author":"Rolfo","year":"2023","journal-title":"npj Precis. Oncol."},{"issue":"2 Pt 1","key":"10.1016\/j.intimp.2024.112816_b0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0190-9622(98)70243-9","article-title":"Treatment of genital warts with an immune-response modifier (imiquimod)","volume":"38","author":"Beutner","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2024.112816_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02370","article-title":"Co-stimulation with TLR7 agonist imiquimod and inactivated influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112816_b0080","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00705-014-2314-x","article-title":"Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection","volume":"160","author":"To","year":"2015","journal-title":"Arch. Virol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112816_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046094","article-title":"Phase 1 study in malaria na\u00efve adults of BSAM2\/Alhydrogel\u00ae+CPG 7909, a blood stage vaccine against P. falciparum malaria","volume":"7","author":"Ellis","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2024.112816_b0090","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/1060028020962050","article-title":"Heplisav-B: a hepatitis B vaccine with a novel adjuvant","volume":"55","author":"Champion","year":"2021","journal-title":"Ann. Pharmacother."},{"issue":"7","key":"10.1016\/j.intimp.2024.112816_b0095","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/cid\/ciac914","article-title":"Impact of vaccination with the SCB-2019 coronavirus disease 2019 vaccine on transmission of severe acute respiratory syndrome coronavirus 2 infection: a household contact study in the Philippines","volume":"76","author":"Tadesse","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"45","key":"10.1016\/j.intimp.2024.112816_b0100","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2005.06.024","article-title":"TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)","volume":"23","author":"Weeratna","year":"2005","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.intimp.2024.112816_b0105","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2020.04.065","article-title":"Improved protection against Chlamydia muridarum using the native major outer membrane protein trapped in Resiquimod-carrying amphipols and effects in protection with addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) adjuvant","volume":"38","author":"Tifrea","year":"2020","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.intimp.2024.112816_b0110","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1016\/j.vaccine.2019.07.093","article-title":"Enhancement of autophagy as a strategy for development of new DNA vaccine candidates against Japanese encephalitis","volume":"37","author":"Zhao","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.intimp.2024.112816_b0115","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/jb.119.3.1072-1074.1974","article-title":"Transformation of Salmonella typhimurium by plasmid deoxyribonucleic acid","volume":"119","author":"Lederberg","year":"1974","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.intimp.2024.112816_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2021.102401","article-title":"Opisthorchis viverrini antigens up-regulates the expression of CD80 and MHC class II in JAWSII mouse dendritic cells and promotes IL-10 and TGF-\u03b2 secretions","volume":"84","author":"Jittimanee","year":"2021","journal-title":"Parasitol. Int."},{"issue":"5","key":"10.1016\/j.intimp.2024.112816_b0125","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/15548627.2020.1756678","article-title":"CYBB\/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation","volume":"17","author":"Keller","year":"2021","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.intimp.2024.112816_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coi.2009.03.011","article-title":"Antigen presentation by dendritic cells in vivo","volume":"21","author":"Segura","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2024.112816_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2022.108427","article-title":"Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice","volume":"244","author":"Nayeri","year":"2023","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112816_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002164","article-title":"Combined TLR7\/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine","volume":"7","author":"Wang","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2024.112816_b0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molimm.2021.01.003","article-title":"Effects of CpG oligodeoxynucleotides on the differentiation of Treg\/Th17 cells","volume":"132","author":"Liu","year":"2021","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112816_b0150","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/eji.201041014","article-title":"Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs","volume":"41","author":"Hackl","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.112816_b0155","article-title":"Significance of regulatory T cells in cancer immunology and immunotherapy","author":"Sugiyama","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112816_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2010.03.002","article-title":"The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus","volume":"262","author":"Salem","year":"2010","journal-title":"Cell. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112816_b0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112816_b0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112816_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008887","article-title":"Luteolin-mediated Kv1.3 K+ channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice","volume":"16","author":"Singh","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2024.112816_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113172","article-title":"Brucella antigens (BhuA, 7\u03b1-HSDH, FliC) in poly I: C adjuvant as potential vaccine candidates against brucellosis","volume":"500","author":"Sadeghi","year":"2022","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.intimp.2024.112816_b0185","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.vaccine.2016.12.069","article-title":"Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine","volume":"35","author":"Luo","year":"2017","journal-title":"Vaccine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:02:41Z","timestamp":1786363361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924013377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"alternative-id":["S1567576924013377"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112816","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the adjuvant effect of imiquimod and CpG ODN 1826 in chimeric DNA vaccine against Japanese encephalitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112816"}}